Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency
- 15 November 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (22), 5951-5954
- https://doi.org/10.1016/j.bmcl.2008.07.072
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- New Lactimidomycin Congeners Shed Insight into Lactimidomycin Biosynthesis in Streptomyces amphibiosporusOrganic Letters, 2007
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- Thermolysis of Isomigrastatin and Its Congeners via [3,3]-Sigmatropic Rearrangement: A New Route to the Synthesis of Migrastatin and Its AnaloguesOrganic Letters, 2006
- Iso-Migrastatin Congeners from Streptomyces platensis and Generation of a Glutarimide Polyketide Library Featuring the Dorrigocin, Lactimidomycin, Migrastatin, and NK30424 ScaffoldsJournal of the American Chemical Society, 2005
- Migrastatin and Dorrigocins Are Shunt Metabolites of Iso-MigrastatinJournal of the American Chemical Society, 2005
- The Migrastatin Family: Discovery of Potent Cell Migration Inhibitors by Chemical SynthesisJournal of the American Chemical Society, 2004
- Discovery of Potent Cell Migration Inhibitors through Total Synthesis: Lessons from Structure−Activity Studies of (+)-MigrastatinJournal of the American Chemical Society, 2004
- Migrastatin, a New Inhibitor of Tumor Cell Migration from Streptomyces sp. MK929-43F1. Taxonomy, Fermentation, Isolation and Biological Activities.The Journal of Antibiotics, 2000
- Isolation, Antifungal Activity, and Structure Elucidation of the Glutarimide Antibiotic, Streptimidone, Produced byMicromonosporacoeruleaJournal of Agricultural and Food Chemistry, 1999
- Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity.The Journal of Antibiotics, 1992